Brain Temporal Dynamics Complexity for Depression Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for depression, such as electroconvulsive therapy (ECT) and magnetic seizure therapy (MST), are effective but have cognitive side effects and unclear biological targets, limiting the development of new interventions with comparable efficacy.
Innovation Solution
Modulating the complexity of temporal dynamics in the brain using seizure or non-seizure therapies, specifically targeting areas like the occipital and parieto-central regions, to reduce temporal complexity and monitor treatment efficacy and cognitive impact.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If seizure therapy (ECT or MST) is used to treat depression, then therapeutic efficacy is improved, but cognitive side effects worsen
Solution Approach 1:
The patent applies local quality by differentiating between fine time-scale complexity (therapeutic target in occipital region) and coarse time-scale complexity (cognitive side effect indicator in parieto-central region). This allows selective modulation of therapeutic effects while monitoring and limiting cognitive adverse effects through region- and scale-specific complexity measurements.
Solution Approach 2:
The patent utilizes parameter changes by measuring complexity across multiple time-scales (fine vs. coarse) and brain regions (occipital vs. parieto-central). These parameter variations enable differentiation between therapeutic response and cognitive side effects, allowing optimization of treatment to maximize efficacy while minimizing harm.
2Reliability
If seizure therapy is used to treat depression, then antidepressant effect is improved, but biological target clarity worsens
Solution Approach 1:
The patent resolves biological target ambiguity by introducing complexity measurements across multiple parameters: time-scales (fine vs. coarse) and brain regions (occipital vs. parieto-central). These parameter distinctions transform the unclear biological target into specific, measurable indicators that clarify the therapeutic mechanism while maintaining antidepressant efficacy.
3Reliability
If complexity of temporal dynamics is reduced in occipital region, then therapeutic success is improved, but if complexity is reduced in parieto-central region, then cognitive side effects are limited
Solution Approach 1:
The patent applies local quality by assigning different functional meanings to complexity changes in different brain regions: occipital region complexity reduction indicates therapeutic success, while parieto-central region complexity reduction indicates cognitive side effect limitation. This spatial differentiation simplifies monitoring by providing region-specific biomarkers for distinct treatment outcomes.
Data Source
AI summary
A method for treating depression in a subject is provided. The method includes treating the subject by providing therapy such as administered through electroconvulsive therapy (ECT) or magnetic seizure therapy (MST). The method further includes evaluating the resulting change in the brain of the subject by measuring complexity of temporal dynamics in the brain of the subject, following treatment, to identify whether complexity of fine time scale temporal dynamics in the fronto-central and/or parieto-occipital region is reduced following treatment. The reduced complexity of fine time scale temporal dynamics in the fronto-central and/or parieto-occipital region following treatment is used to identify the subject as a responder to the therapy for treating depression. The step of evaluating further comprises identifying change in complexity of coarse scale temporal dynamics in a parieto-central region following treatment.